Live Breaking News & Updates on Biolinerx ltd

Stay informed with the latest breaking news from Biolinerx ltd on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Biolinerx ltd and stay connected to the pulse of your community

BioLineRx (NASDAQ:BLRX) Lifted to Sell at StockNews.com

StockNews.com upgraded shares of BioLineRx (NASDAQ:BLRX – Free Report) to a sell rating in a report published on Tuesday morning. Separately, HC Wainwright reissued a buy rating and issued a $21.00 price objective on shares of BioLineRx in a research note on Wednesday, April 17th. View Our Latest Analysis on BioLineRx BioLineRx Stock Performance NASDAQ:BLRX […]

Northrock-partners , First-advisors-inc , Biolinerx-ltd , Rathbones-group , Nasdaq , Asset-management-corp , Allen-mooney-barnes-investment-advisors , Biolinerx-company-profile , Free-report , Get-free-report , Management-corp

BioLineRx (NASDAQ:BLRX) Upgraded at StockNews.com

BioLineRx (NASDAQ:BLRX – Get Free Report) was upgraded by equities research analysts at StockNews.com to a “sell” rating in a research report issued on Tuesday. Separately, HC Wainwright restated a “buy” rating and set a $21.00 target price on shares of BioLineRx in a research note on Wednesday, April 17th. Check Out Our Latest Report […]

Northrock-partners , First-advisors-inc , B-riley-wealth-advisors-inc , Allen-mooney-barnes-investment-advisors , Biolinerx-ltd , Rathbones-group , Nasdaq , Biolinerx-company-profile , Get-free-report , Linerx-stock-down , Riley-wealth-advisors

StockNews.com Upgrades BioLineRx (NASDAQ:BLRX) to Sell

BioLineRx (NASDAQ:BLRX – Get Free Report) was upgraded by investment analysts at StockNews.com to a “sell” rating in a research report issued to clients and investors on Tuesday. Separately, HC Wainwright reiterated a “buy” rating and set a $21.00 price target on shares of BioLineRx in a report on Wednesday, April 17th. Check Out Our […]

First-advisors-inc , Biolinerx-ltd , Allen-mooney-barnes-investment-advisors , B-riley-wealth-advisors-inc , Biolinerx-company-profile , Asset-management-corp , Rathbones-group , Get-free-report , Management-corp , First-advisors , Barnes-investment-advisors

BioLineRx Accesses Second Tranche of $20 Million Under Previously Announced $40 Million Non-Dilutive Debt Financing Agreement

/PRNewswire/ -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare...

Israel , China , Russia , Ukraine , United-states , Russian , Gloria-biosciences , Philip-serlin , Moran-meir , John-lacey , Blackrock , Washington-university-school-of-medicine

BioLineRx Announces $6 Million Registered Direct Offering

BioLineRx Announces $6 Million Registered Direct Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Israel , New-york , Russia , Ukraine , Russian , John-lacey , Moran-meir , Philip-serlin , Biolinerx-adss , Jonestrading-institutional-services , Company-american-depositary-shares-adss

BioLineRx (BLRX) Announces 7.5M Share Offering at $0.80/sh

BioLineRx (BLRX) Announces 7.5M Share Offering at $0.80/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Philip-serlin , Nasdaq , Exchange-commission , Jonestrading-institutional-services , Company-american-depositary-shares-adss , Biolinerx-ltd , American-depositary-shares , Chief-executive-officer , Equity-capital-markets ,

BioLineRx (NASDAQ:BLRX) Announces Quarterly Earnings Results, Beats Estimates By $0.07 EPS

BioLineRx (NASDAQ:BLRX) Announces Quarterly Earnings Results, Beats Estimates By $0.07 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Biolinerx-ltd , Renaissance-technologies , Envestnet-asset-management-inc , Atria-wealth-solutions-inc , Get-free-report , Wealth-solutions , Envestnet-asset-management , Linerx-ltd , Biolinerx-daily ,

BioLineRx (NASDAQ:BLRX) Posts Earnings Results, Beats Expectations By $0.07 EPS

BioLineRx (NASDAQ:BLRX – Get Free Report) issued its earnings results on Thursday. The biotechnology company reported ($0.15) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.07, Zacks reports. The company had revenue of $4.80 million for the quarter, compared to analysts’ expectations of $0.17 million. During the same period […]

Renaissance-technologies , Envestnet-asset-management-inc , Biolinerx-company-profile , Biolinerx-ltd , Atria-wealth-solutions-inc , Get-free-report , Asset-management , Atria-wealth-solutions , Linerx-ltd , Biolinerx-daily , Biolinerx

BioLineRx (NASDAQ:BLRX) Announces Earnings Results

BioLineRx (NASDAQ:BLRX) Announces Earnings Results
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Nasdaq , Renaissance-technologies , Envestnet-asset-management-inc , Atria-wealth-solutions-inc , Biolinerx-ltd , Biolinerx-company-profile , Get-free-report , Wealth-solutions , Asset-management , Linerx-ltd , Biolinerx-daily

BioLineRx (NASDAQ:BLRX) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS

BioLineRx (NASDAQ:BLRX – Get Free Report) announced its quarterly earnings data on Thursday. The biotechnology company reported ($0.15) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.07, Zacks reports. The firm had revenue of $4.80 million for the quarter, compared to analysts’ expectations of $0.17 million. During the same […]

Nasdaq , Renaissance-technologies , Envestnet-asset-management-inc , Atria-wealth-solutions-inc , Biolinerx-ltd , Get-free-report , Asset-management , Atria-wealth-solutions , Linerx-ltd , Biolinerx-daily , Biolinerx